ChemicalBook > Product Catalog >API >Antineoplastic agents >Other antineoplastic Drugs >Cetuximab

Cetuximab

Cetuximab Structure
CAS No.
205923-56-4
Chemical Name:
Cetuximab
Synonyms
EGFR antibody;IMC 225;Hsdb 7454;CETUXIMAB;CetuxiMab(C225);Unii-pqx0D8J21j;CETUXIMAB USP/EP/BP;Cetuximab (anti-EGFR);Research Grade Cetuximab;6-Diaminoheptanedioic acid
CBNumber:
CB82448505
Molecular Formula:
C107H179N35O36S7
Molecular Weight:
2756.23406
MOL File:
205923-56-4.mol
Modify Date:
2025/4/28 21:36:36

Cetuximab Properties

storage temp. Store at 4°C, do not freeze
form Liquid
color Colorless to light yellow

SAFETY

Risk and Safety Statements

Hazardous Substances Data 205923-56-4(Hazardous Substances Data)

Cetuximab Chemical Properties,Uses,Production

Originator

ImClone (US)

Uses

Treatment of EGF receptor-expressing cancers (monoclonal antibod.

brand name

Erbitux

Mechanism of action

Cetuximab, a monoclonal antibody, binds to the extracellular domain of the EGFR, which is overexpressed in many human cancers, including head, neck, and colorectal types. This process prevents the EGFR from binding with its endogenous ligand, blocking the receptor-dependent transduction pathway and providing many antitumor effects involving cell-cycle arrest, induction of apoptosis, inhibition of angiogenesis, inhibition of metastasis, internalization, and downregulation of the EGFR, and enhancement of the sensitivity to radiochemotherapy[1].
Cetuximab

Toxicology

The majority of skin toxicities were mild to moderate, symptomatic treatments were effective in controlling them. The skin discomfort caused by cetuximab can affect the quality of life temporarily; with long term treatment, severity of skin toxicity may decrease.

References

[1] W Bou-Assaly, S Mukherji. “Cetuximab (erbitux).” American Journal of Neuroradiology 31 4 (2010): 626–7.

Cetuximab Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 187)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6257 58 Inquiry
Medicea Impex Private Limited 07942544983 Nagpur, India 24 58 Inquiry
Shanghai Minbiotech Co., Ltd. +8617315815539 CHINA 129 58 Inquiry
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. +86-18600796368 +86-18600796368 China 485 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21628 55 Inquiry
BOC Sciences +1-631-485-4226 United States 19552 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29808 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 32222 58 Inquiry
Hubei Ipure Biology Co., Ltd +8613367258412 China 10244 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 22855 58 Inquiry

Related articles

  • The Uses and indications Cetuximab
  • Cetuximab is a chimeric human-murine monoclonal antibody against EGFR.Cutaneous side effects are the most common adverse react....
  • Jan 26,2025
CETUXIMAB Hsdb 7454 Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer Unii-pqx0D8J21j CetuxiMab(C225) IMC 225 Cetuximab (anti-EGFR) CETUXIMAB USP/EP/BP 6-Diaminoheptanedioic acid EGFR antibody Research Grade Cetuximab(DHB86902) ImmunoglobulinG1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 g1-chain),disulfide with human-mouse monoclonal C225 k-chain, dimer Research Grade Cetuximab Cetuximab - Buffer solution 205923-56-4 C6484H10042N1732O2023S36